Literature DB >> 15255977

Anatomical and functional evidence for a role of arginine-vasopressin (AVP) in rat olfactory epithelium cells.

Grégoire Levasseur1, Christine Baly, Denise Grébert, Didier Durieux, Roland Salesse, Monique Caillol.   

Abstract

The olfactory epithelium (OE) is composed of olfactory sensory neurons (OSNs) and sustentacular cells; it lies in the nasal cavity where it is protected by a thin mucus layer. The finely regulated composition of this mucus provides OSN with a suitable ionic environment. To maintain the functional integrity of the epithelium despite permanent physical, chemical and microbial aggressions, both OSNs and surrounding sustentacular cells are continuously renewed from globose basal cells. Moreover, the sense of smell is involved in so numerous behaviours (feeding, reproduction, etc.) that it has to cross-talk with the endocrine and neuroendocrine systems. Thus, besides its sensory function, the olfactory epithelium is thought to undergo a lot of complex regulatory processes. We therefore studied the effects of various neuropeptides on primary cultures of Sprague-Dawley rat olfactory epithelium cells. We found that arginine-vasopressin (AVP) triggered a robust, dose-dependent calcium increase in these cells. The cell response was essentially ascribed to the V1a AVP receptor, whose presence was confirmed by RT-PCR and immunolabelling. In the culture, V1a but not V1b receptors were present, mainly localized in neurons. In the epithelium, both subtypes were found differentially distributed. V1a-R were localized mainly in globose basal cells and at the apical side of the epithelium, in the area of the dendritic knobs of OSNs. V1b-R were strongly associated with Bowman's gland cells and globose basal cells. These localizations suggested potential multifaceted roles of a hormone, AVP, in the olfactory epithelium.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15255977     DOI: 10.1111/j.1460-9568.2004.03516.x

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  8 in total

1.  Intranasal application of vasopressin fails to elicit changes in brain immediate early gene expression, neural activity and behavioural performance of rats.

Authors:  M Ludwig; V A Tobin; M F Callahan; E Papadaki; A Becker; M Engelmann; G Leng
Journal:  J Neuroendocrinol       Date:  2013-07       Impact factor: 3.627

2.  Increased vasopressin transmission from the paraventricular nucleus to the rostral medulla augments cardiorespiratory outflow in chronic intermittent hypoxia-conditioned rats.

Authors:  Prabha Kc; Kannan V Balan; Steven S Tjoe; Richard J Martin; Joseph C Lamanna; Musa A Haxhiu; Thomas E Dick
Journal:  J Physiol       Date:  2010-01-05       Impact factor: 5.182

Review 3.  Peripheral modulation of smell: fact or fiction?

Authors:  Mary T Lucero
Journal:  Semin Cell Dev Biol       Date:  2012-09-15       Impact factor: 7.727

Review 4.  Vasopressin Proves Es-sense-tial: Vasopressin and the Modulation of Sensory Processing in Mammals.

Authors:  Janet K Bester-Meredith; Alexandria P Fancher; Grace E Mammarella
Journal:  Front Endocrinol (Lausanne)       Date:  2015-02-05       Impact factor: 5.555

Review 5.  The role of vasopressin in olfactory and visual processing.

Authors:  Douglas Wacker; Mike Ludwig
Journal:  Cell Tissue Res       Date:  2018-06-27       Impact factor: 5.249

6.  AVPR1A distribution in the whole C57BL/6J mouse neonate.

Authors:  Katherine R Day; Alexis Coleman; Maria A Greenwood; Elizabeth A D Hammock
Journal:  Sci Rep       Date:  2020-09-03       Impact factor: 4.379

7.  Effects of route of administration on oxytocin-induced changes in regional cerebral blood flow in humans.

Authors:  D A Martins; N Mazibuko; F Zelaya; S Vasilakopoulou; J Loveridge; A Oates; S Maltezos; M Mehta; S Wastling; M Howard; G McAlonan; D Murphy; S C R Williams; A Fotopoulou; U Schuschnig; Y Paloyelis
Journal:  Nat Commun       Date:  2020-03-03       Impact factor: 14.919

8.  Intranasal administration of oxytocin: behavioral and clinical effects, a review.

Authors:  Jan G Veening; Berend Olivier
Journal:  Neurosci Biobehav Rev       Date:  2013-05-04       Impact factor: 8.989

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.